- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Hyper Immune Globulin will have significant change from previous year. By the most conservative estimates of global Hyper Immune Globulin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Hyper Immune Globulin market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Hyper Immune Globulin market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Hyper Immune Globulin, covering the supply chain analysis, impact assessment to the Hyper Immune Globulin market size growth rate in several scenarios, and the measures to be undertaken by Hyper Immune Globulin companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Government Institutions
Private Sector
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Behring
Shanghai RAAS
Grifols
Kedrion
CBPO
Biotest
CNBG
Emergent (Cangene)
Hualan Bio
Kamada
Sichuan Yuanda Shuyang
ADMA Biologics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hyper Immune Globulin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Hyper Immune Globulin market by identifying its various subsegments.
Focuses on the key global Hyper Immune Globulin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hyper Immune Globulin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hyper Immune Globulin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Hyper Immune Globulin?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Hyper Immune Globulin Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hyper Immune Globulin Consumption 2015-2025
2.1.2 Hyper Immune Globulin Consumption CAGR by Region
2.2 Hyper Immune Globulin Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Rho(D) Immunoglobulins
2.2.5 Others
2.3 Hyper Immune Globulin Consumption by Type
2.3.1 Global Hyper Immune Globulin Consumption Market Share by Type (2015-2020)
2.3.2 Global Hyper Immune Globulin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Hyper Immune Globulin Sale Price by Type (2015-2020)
2.4 Hyper Immune Globulin Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Others
2.5 Hyper Immune Globulin Consumption by Application
2.5.1 Global Hyper Immune Globulin Consumption Market Share by Type (2015-2020)
2.5.2 Global Hyper Immune Globulin Value and Market Share by Type (2015-2020)
2.5.3 Global Hyper Immune Globulin Sale Price by Type (2015-2020)
3 Global Hyper Immune Globulin by Company
3.1 Global Hyper Immune Globulin Sales Market Share by Company
3.1.1 Global Hyper Immune Globulin Sales by Company (2018-2020)
3.1.2 Global Hyper Immune Globulin Sales Market Share by Company (2018-2020)
3.2 Global Hyper Immune Globulin Revenue Market Share by Company
3.2.1 Global Hyper Immune Globulin Revenue by Company (2018-2020)
3.2.2 Global Hyper Immune Globulin Revenue Market Share by Company (2018-2020)
3.3 Global Hyper Immune Globulin Sale Price by Company
3.4 Global Hyper Immune Globulin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Hyper Immune Globulin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Hyper Immune Globulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hyper Immune Globulin by Regions
4.1 Hyper Immune Globulin by Regions
4.2 Americas Hyper Immune Globulin Consumption Growth
4.3 APAC Hyper Immune Globulin Consumption Growth
4.4 Europe Hyper Immune Globulin Consumption Growth
4.5 Middle East & Africa Hyper Immune Globulin Consumption Growth
5 Americas
5.1 Americas Hyper Immune Globulin Consumption by Countries
5.1.1 Americas Hyper Immune Globulin Consumption by Countries (2015-2020)
5.1.2 Americas Hyper Immune Globulin Value by Countries (2015-2020)
5.2 Americas Hyper Immune Globulin Consumption by Type
5.3 Americas Hyper Immune Globulin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hyper Immune Globulin Consumption by Regions
6.1.1 APAC Hyper Immune Globulin Consumption by Regions (2015-2020)
6.1.2 APAC Hyper Immune Globulin Value by Regions (2015-2020)
6.2 APAC Hyper Immune Globulin Consumption by Type
6.3 APAC Hyper Immune Globulin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Hyper Immune Globulin by Countries
7.1.1 Europe Hyper Immune Globulin Consumption by Countries (2015-2020)
7.1.2 Europe Hyper Immune Globulin Value by Countries (2015-2020)
7.2 Europe Hyper Immune Globulin Consumption by Type
7.3 Europe Hyper Immune Globulin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Hyper Immune Globulin by Countries
8.1.1 Middle East & Africa Hyper Immune Globulin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Hyper Immune Globulin Value by Countries (2015-2020)
8.2 Middle East & Africa Hyper Immune Globulin Consumption by Type
8.3 Middle East & Africa Hyper Immune Globulin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hyper Immune Globulin Distributors
10.3 Hyper Immune Globulin Customer
11 Global Hyper Immune Globulin Market Forecast
11.1 Global Hyper Immune Globulin Consumption Forecast (2021-2025)
11.2 Global Hyper Immune Globulin Forecast by Regions
11.2.1 Global Hyper Immune Globulin Forecast by Regions (2021-2025)
11.2.2 Global Hyper Immune Globulin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hyper Immune Globulin Forecast by Type
11.8 Global Hyper Immune Globulin Forecast by Application
12 Key Players Analysis
12.1 CSL Behring
12.1.1 Company Information
12.1.2 Hyper Immune Globulin Product Offered
12.1.3 CSL Behring Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Behring Latest Developments
12.2 Shanghai RAAS
12.2.1 Company Information
12.2.2 Hyper Immune Globulin Product Offered
12.2.3 Shanghai RAAS Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shanghai RAAS Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 Hyper Immune Globulin Product Offered
12.3.3 Grifols Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Kedrion
12.4.1 Company Information
12.4.2 Hyper Immune Globulin Product Offered
12.4.3 Kedrion Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Kedrion Latest Developments
12.5 CBPO
12.5.1 Company Information
12.5.2 Hyper Immune Globulin Product Offered
12.5.3 CBPO Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 CBPO Latest Developments
12.6 Biotest
12.6.1 Company Information
12.6.2 Hyper Immune Globulin Product Offered
12.6.3 Biotest Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Biotest Latest Developments
12.7 CNBG
12.7.1 Company Information
12.7.2 Hyper Immune Globulin Product Offered
12.7.3 CNBG Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CNBG Latest Developments
12.8 Emergent (Cangene)
12.8.1 Company Information
12.8.2 Hyper Immune Globulin Product Offered
12.8.3 Emergent (Cangene) Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Emergent (Cangene) Latest Developments
12.9 Hualan Bio
12.9.1 Company Information
12.9.2 Hyper Immune Globulin Product Offered
12.9.3 Hualan Bio Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Hualan Bio Latest Developments
12.10 Kamada
12.10.1 Company Information
12.10.2 Hyper Immune Globulin Product Offered
12.10.3 Kamada Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Kamada Latest Developments
12.11 Sichuan Yuanda Shuyang
12.11.1 Company Information
12.11.2 Hyper Immune Globulin Product Offered
12.11.3 Sichuan Yuanda Shuyang Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Sichuan Yuanda Shuyang Latest Developments
12.12 ADMA Biologics
12.12.1 Company Information
12.12.2 Hyper Immune Globulin Product Offered
12.12.3 ADMA Biologics Hyper Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 ADMA Biologics Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Hyper Immune Globulin Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Hyper Immune Globulin Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Hyper Immune Globulin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Hepatitis B Immunoglobulins
Table 7. Major Players of Rabies Immunoglobulins
Table 8. Major Players of Tetanus Immunoglobulins
Table 9. Major Players of Rho(D) Immunoglobulins
Table 10. Major Players of Others
Table 11. Global Consumption Sales by Type (2015-2020)
Table 12. Global Hyper Immune Globulin Consumption Market Share by Type (2015-2020)
Table 13. Global Hyper Immune Globulin Revenue by Type (2015-2020) ($ million)
Table 14. Global Hyper Immune Globulin Value Market Share by Type (2015-2020) ($ Millions)
Table 15. Global Hyper Immune Globulin Sale Price by Type (2015-2020)
Table 16. Global Consumption Sales by Application (2015-2020)
Table 17. Global Hyper Immune Globulin Consumption Market Share by Application (2015-2020)
Table 18. Global Hyper Immune Globulin Value by Application (2015-2020)
Table 19. Global Hyper Immune Globulin Value Market Share by Application (2015-2020)
Table 20. Global Hyper Immune Globulin Sale Price by Application (2015-2020)
Table 21. Global Hyper Immune Globulin Sales by Company (2017-2019) (K Units)
Table 22. Global Hyper Immune Globulin Sales Market Share by Company (2017-2019)
Table 23. Global Hyper Immune Globulin Revenue by Company (2017-2019) ($ Millions)
Table 24. Global Hyper Immune Globulin Revenue Market Share by Company (2017-2019)
Table 25. Global Hyper Immune Globulin Sale Price by Company (2017-2019)
Table 26. Global Hyper Immune Globulin Manufacturing Base Distribution and Sales Area by Manufacturers
Table 27. Players Hyper Immune Globulin Products Offered
Table 28. Hyper Immune Globulin Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 29. Global Hyper Immune Globulin Consumption by Regions 2015-2020 (K Units)
Table 30. Global Hyper Immune Globulin Consumption Market Share by Regions 2015-2020
Table 31. Global Hyper Immune Globulin Value by Regions 2015-2020 ($ Millions)
Table 32. Global Hyper Immune Globulin Value Market Share by Regions 2015-2020
Table 33. Americas Hyper Immune Globulin Consumption by Countries (2015-2020) (K Units)
Table 34. Americas Hyper Immune Globulin Consumption Market Share by Countries (2015-2020)
Table 35. Americas Hyper Immune Globulin Value by Countries (2015-2020) ($ Millions)
Table 36. Americas Hyper Immune Globulin Value Market Share by Countries (2015-2020)
Table 37. Americas Hyper Immune Globulin Consumption by Type (2015-2020) (K Units)
Table 38. Americas Hyper Immune Globulin Consumption Market Share by Type (2015-2020)
Table 39. Americas Hyper Immune Globulin Consumption by Application (2015-2020) (K Units)
Table 40. Americas Hyper Immune Globulin Consumption Market Share by Application (2015-2020)
Table 41. APAC Hyper Immune Globulin Consumption by Countries (2015-2020) (K Units)
Table 42. APAC Hyper Immune Globulin Consumption Market Share by Countries (2015-2020)
Table 43. APAC Hyper Immune Globulin Value by Regions (2015-2020) ($ Millions)
Table 44. APAC Hyper Immune Globulin Value Market Share by Regions (2015-2020)
Table 45. APAC Hyper Immune Globulin Consumption by Type (2015-2020) (K Units)
Table 46. APAC Hyper Immune Globulin Consumption Market Share by Type (2015-2020)
Table 47. APAC Hyper Immune Globulin Consumption by Application (2015-2020) (K Units)
Table 48. APAC Hyper Immune Globulin Consumption Market Share by Application (2015-2020)
Table 49. Europe Hyper Immune Globulin Consumption by Countries (2015-2020) (K Units)
Table 50. Europe Hyper Immune Globulin Consumption Market Share by Countries (2015-2020)
Table 51. Europe Hyper Immune Globulin Value by Countries (2015-2020) ($ Millions)
Table 52. Europe Hyper Immune Globulin Value Market Share by Countries (2015-2020)
Table 53. Europe Hyper Immune Globulin Consumption by Type (2015-2020) (K Units)
Table 54. Europe Hyper Immune Globulin Consumption Market Share by Type (2015-2020)
Table 55. Europe Hyper Immune Globulin Consumption by Application (2015-2020) (K Units)
Table 56. Europe Hyper Immune Globulin Consumption Market Share by Application (2015-2020)
Table 57. Middle East & Africa Hyper Immune Globulin Consumption by Countries (2015-2020) (K Units)
Table 58. Middle East & Africa Hyper Immune Globulin Consumption Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Hyper Immune Globulin Value by Countries (2015-2020) ($ Millions)
Table 60. Middle East & Africa Hyper Immune Globulin Value Market Share by Countries (2015-2020)
Table 61. Middle East & Africa Hyper Immune Globulin Consumption by Type (2015-2020) (K Units)
Table 62. Middle East & Africa Hyper Immune Globulin Consumption Market Share by Type (2015-2020)
Table 63. Middle East & Africa Hyper Immune Globulin Consumption by Application (2015-2020) (K Units)
Table 64. Middle East & Africa Hyper Immune Globulin Consumption Market Share by Application (2015-2020)
Table 65. Hyper Immune Globulin Distributors List
Table 66. Hyper Immune Globulin Customer List
Table 67. Global Hyper Immune Globulin Consumption Forecast by Countries (2021-2025) (K Units)
Table 68. Global Hyper Immune Globulin Consumption Market Forecast by Regions
Table 69. Global Hyper Immune Globulin Value Forecast by Countries (2021-2025) ($ Millions)
Table 70. Global Hyper Immune Globulin Value Market Share Forecast by Regions
Table 71. Global Hyper Immune Globulin Consumption Forecast by Type (2021-2025) (K Units)
Table 72. Global Hyper Immune Globulin Consumption Market Share Forecast by Type (2021-2025)
Table 73. Global Hyper Immune Globulin Value Forecast by Type (2021-2025) ($ Millions)
Table 74. Global Hyper Immune Globulin Value Market Share Forecast by Type (2021-2025)
Table 75. Global Hyper Immune Globulin Consumption Forecast by Application (2021-2025) (K Units)
Table 76. Global Hyper Immune Globulin Consumption Market Share Forecast by Application (2021-2025)
Table 77. Global Hyper Immune Globulin Value Forecast by Application (2021-2025) ($ Millions)
Table 78. Global Hyper Immune Globulin Value Market Share Forecast by Application (2021-2025)
Table 79. CSL Behring Product Offered
Table 80. CSL Behring Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. CSL Behring Main Business
Table 82. CSL Behring Latest Developments
Table 83. CSL Behring Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Shanghai RAAS Product Offered
Table 85. Shanghai RAAS Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Shanghai RAAS Main Business
Table 87. Shanghai RAAS Latest Developments
Table 88. Shanghai RAAS Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 89. Grifols Product Offered
Table 90. Grifols Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Grifols Main Business
Table 92. Grifols Latest Developments
Table 93. Grifols Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Kedrion Product Offered
Table 95. Kedrion Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Kedrion Main Business
Table 97. Kedrion Latest Developments
Table 98. Kedrion Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 99. CBPO Product Offered
Table 100. CBPO Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. CBPO Main Business
Table 102. CBPO Latest Developments
Table 103. CBPO Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Biotest Product Offered
Table 105. Biotest Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 106. Biotest Main Business
Table 107. Biotest Latest Developments
Table 108. Biotest Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 109. CNBG Product Offered
Table 110. CNBG Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 111. CNBG Main Business
Table 112. CNBG Latest Developments
Table 113. CNBG Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 114. Emergent (Cangene) Product Offered
Table 115. Emergent (Cangene) Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. Emergent (Cangene) Main Business
Table 117. Emergent (Cangene) Latest Developments
Table 118. Emergent (Cangene) Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 119. Hualan Bio Product Offered
Table 120. Hualan Bio Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 121. Hualan Bio Main Business
Table 122. Hualan Bio Latest Developments
Table 123. Hualan Bio Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 124. Kamada Product Offered
Table 125. Kamada Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 126. Kamada Main Business
Table 127. Kamada Latest Developments
Table 128. Kamada Basic Information, Company Total Revenue (in $ million), Hyper Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 129. Sichuan Yuanda Shuyang Product Offered
Table 130. Sichuan Yuanda Shuyang Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 131. Sichuan Yuanda Shuyang Main Business
Table 132. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Sichuan Yuanda Shuyang Latest Developments
Table 134. ADMA Biologics Product Offered
Table 135. ADMA Biologics Hyper Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 136. ADMA Biologics Main Business
Table 137. ADMA Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 138. ADMA Biologics Latest Developments
List of Figures
Figure 1. Picture of Hyper Immune Globulin
Figure 2. Hyper Immune Globulin Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Hyper Immune Globulin Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Hyper Immune Globulin Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Hepatitis B Immunoglobulins
Figure 7. Product Picture of Rabies Immunoglobulins
Figure 8. Product Picture of Tetanus Immunoglobulins
Figure 9. Product Picture of Rho(D) Immunoglobulins
Figure 10. Product Picture of Others
Figure 11. Global Hyper Immune Globulin Consumption Market Share by Type (2015-2020)
Figure 12. Global Hyper Immune Globulin Value Market Share by Type (2015-2020)
Figure 13. Hyper Immune Globulin Consumed in Government Institutions
Figure 14. Global Hyper Immune Globulin Market: Government Institutions (2015-2020) (K Units)
Figure 15. Global Hyper Immune Globulin Market: Government Institutions (2015-2020) ($ Millions)
Figure 16. Hyper Immune Globulin Consumed in Private Sector
Figure 17. Global Hyper Immune Globulin Market: Private Sector (2015-2020) (K Units)
Figure 18. Global Hyper Immune Globulin Market: Private Sector (2015-2020) ($ Millions)
Figure 19. Hyper Immune Globulin Consumed in Others
Figure 20. Global Hyper Immune Globulin Market: Others (2015-2020) (K Units)
Figure 21. Global Hyper Immune Globulin Market: Others (2015-2020) ($ Millions)
Figure 22. Global Hyper Immune Globulin Consumption Market Share by Application (2015-2020)
Figure 23. Global Hyper Immune Globulin Value Market Share by Application (2015-2020)
Figure 24. Global Hyper Immune Globulin Sales Market Share by Company in 2017
Figure 25. Global Hyper Immune Globulin Sales Market Share by Company in 2019
Figure 26. Global Hyper Immune Globulin Revenue Market Share by Company in 2017
Figure 27. Global Hyper Immune Globulin Revenue Market Share by Company in 2019
Figure 28. Global Hyper Immune Globulin Sale Price by Company in 2019
Figure 29. Global Hyper Immune Globulin Consumption Market Share by Regions 2015-2020
Figure 30. Global Hyper Immune Globulin Value Market Share by Regions 2015-2020
Figure 31. Americas Hyper Immune Globulin Consumption 2015-2020 (K Units)
Figure 32. Americas Hyper Immune Globulin Value 2015-2020 ($ Millions)
Figure 33. APAC Hyper Immune Globulin Consumption 2015-2020 (K Units)
Figure 34. APAC Hyper Immune Globulin Value 2015-2020 ($ Millions)
Figure 35. Europe Hyper Immune Globulin Consumption 2015-2020 (K Units)
Figure 36. Europe Hyper Immune Globulin Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Hyper Immune Globulin Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Hyper Immune Globulin Value 2015-2020 ($ Millions)
Figure 39. Americas Hyper Immune Globulin Consumption Market Share by Countries in 2019
Figure 40. Americas Hyper Immune Globulin Value Market Share by Countries in 2019
Figure 41. Americas Hyper Immune Globulin Consumption Market Share by Type in 2019
Figure 42. Americas Hyper Immune Globulin Consumption Market Share by Application in 2019
Figure 43. United States Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 44. United States Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 46. Canada Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 48. Mexico Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Hyper Immune Globulin Consumption Market Share by Countries in 2019
Figure 50. APAC Hyper Immune Globulin Value Market Share by Regions in 2019
Figure 51. APAC Hyper Immune Globulin Consumption Market Share by Type in 2019
Figure 52. APAC Hyper Immune Globulin Consumption Market Share by Application in 2019
Figure 53. China Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 54. China Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 56. Japan Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 58. Korea Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 60. Southeast Asia Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 61. India Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 62. India Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 64. Australia Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Hyper Immune Globulin Consumption Market Share by Countries in 2019
Figure 66. Europe Hyper Immune Globulin Value Market Share by Countries in 2019
Figure 67. Europe Hyper Immune Globulin Consumption Market Share by Type in 2019
Figure 68. Europe Hyper Immune Globulin Consumption Market Share by Application in 2019
Figure 69. Germany Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 70. Germany Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 71. France Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 72. France Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 73. UK Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 74. UK Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 76. Italy Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 78. Russia Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Hyper Immune Globulin Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Hyper Immune Globulin Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Hyper Immune Globulin Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Hyper Immune Globulin Consumption Market Share by Application in 2019
Figure 83. Egypt Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Hyper Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Hyper Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 93. Global Hyper Immune Globulin Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Hyper Immune Globulin Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 96. Americas Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 97. APAC Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 98. APAC Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 99. Europe Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 100. Europe Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 103. United States Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 104. United States Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 105. Canada Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 106. Canada Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 107. Mexico Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 108. Mexico Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 109. Brazil Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 110. Brazil Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 111. China Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 112. China Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 113. Japan Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 114. Japan Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 115. Korea Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 116. Korea Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 118. Southeast Asia Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 119. India Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 120. India Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 121. Australia Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 122. Australia Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 123. Germany Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 124. Germany Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 125. France Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 126. France Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 127. UK Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 128. UK Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 129. Italy Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 130. Italy Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 131. Russia Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 132. Russia Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 133. Spain Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 134. Spain Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 135. Egypt Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 136. Egypt Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 137. South Africa Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 138. South Africa Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 139. Israel Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 140. Israel Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 141. Turkey Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 142. Turkey Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Hyper Immune Globulin Consumption 2021-2025 (K Units)
Figure 144. GCC Countries Hyper Immune Globulin Value 2021-2025 ($ Millions)
Figure 145. CSL Behring Hyper Immune Globulin Market Share (2018-2020)
Figure 146. Shanghai RAAS Hyper Immune Globulin Market Share (2018-2020)
Figure 147. Grifols Hyper Immune Globulin Market Share (2018-2020)
Figure 148. Kedrion Hyper Immune Globulin Market Share (2018-2020)
Figure 149. CBPO Hyper Immune Globulin Market Share (2018-2020)
Figure 150. Biotest Hyper Immune Globulin Market Share (2018-2020)
Figure 151. CNBG Hyper Immune Globulin Market Share (2018-2020)
Figure 152. Emergent (Cangene) Hyper Immune Globulin Market Share (2018-2020)
Figure 153. Hualan Bio Hyper Immune Globulin Market Share (2018-2020)
Figure 154. Kamada Hyper Immune Globulin Market Share (2018-2020)
Figure 155. Sichuan Yuanda Shuyang Hyper Immune Globulin Market Share (2018-2020)
Figure 156. ADMA Biologics Hyper Immune Globulin Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
